Integra LifeSciences Holdings Corporation
IART · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,746,587 | $3,404,260 | $4,653,642 | $5,673,919 |
| - Cash | $246,375 | $276,402 | $456,661 | $513,448 |
| + Debt | $1,984,563 | $1,681,682 | $1,615,359 | $1,651,287 |
| Enterprise Value | $3,484,775 | $4,809,540 | $5,812,340 | $6,811,758 |
| Revenue | $1,610,527 | $1,541,573 | $1,557,666 | $1,542,448 |
| % Growth | 4.5% | -1% | 1% | – |
| Gross Profit | $882,061 | $884,735 | $970,311 | $944,640 |
| % Margin | 54.8% | 57.4% | 62.3% | 61.2% |
| EBITDA | $193,288 | $255,958 | $384,603 | $366,331 |
| % Margin | 12% | 16.6% | 24.7% | 23.7% |
| Net Income | -$6,944 | $67,741 | $180,550 | $169,075 |
| % Margin | -0.4% | 4.4% | 11.6% | 11% |
| EPS Diluted | -0.09 | 0.84 | 2.16 | 1.98 |
| % Growth | -110.7% | -61.1% | 9.1% | – |
| Operating Cash Flow | $129,382 | $139,955 | $264,469 | $312,427 |
| Capital Expenditures | -$104,418 | -$66,865 | -$47,085 | -$48,080 |
| Free Cash Flow | $24,964 | $73,090 | $217,384 | $264,347 |